Kazuhiro Ikegai

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 5 EPO patents. Top assignees: Astellas Pharma Gmbh, Kotobuki Pharmaceutical Co Ltd, Kotobuki Pharmaceuticals Co., Ltd.. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Ikegai. Retrieved from https://idiyas.com/inventor/kazuhiro-ikegai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 20.0

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 8.6

ph-index = 4

Forward Citations = 166(Granted Patents)

Location History:

Tsukuba, JP (2007)
Chuo-ku, JP (2009 - 2010)
Tokyo, JP (2007 - 2016)

Company Filing History:

Kotobuki Pharmaceutical Co Ltd

patents

1 out of 2

Kotobuki Pharmaceuticals Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2007-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9399038 - Benzothiophene compound (2016-07-26),

2. 8981119 - Benzothiophene compound (2015-03-17),

3. 8598355 - Amide compound (2013-12-03),

4. 8153658 - Piperidine derivative or salt thereof (2012-04-10),

5. 7977466 - C-glycoside derivatives and salts thereof (2011-07-12),

6. 7855198 - Benzamide derivative or salt thereof (2010-12-21),

7. 7772407 - C-glycoside derivatives and salts thereof (2010-08-10),

8. 7585878 - Benzamide derivative or salt thereof (2009-09-08),

9. 7202350 - C-glycoside derivatives and salts thereof (2007-04-10),

10. 7169761 - Azulene derivatives and salts thereof (2007-01-30),

Title: The Innovative Path of Kazuhiro Ikegai: A Tokyo-based Inventor with 10 Patents

Introduction:

Kazuhiro Ikegai, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. With a total of 10 patents to his name, Ikegai's work focuses on developing compounds to treat a range of challenging medical conditions.

Latest Patents:

Among his recent patents is the Benzothiophene compound, a method for preventing or treating diseases such as visceral pain, inflammatory pain, osteoarthritis pain, neuropathic pain, and fibromyalgia. This compound, represented by the formula (I) or its salt, offers new possibilities for effective pain management and treatment.

Career Highlights:

Ikegai has honed his expertise through his tenure at renowned companies such as Astellas Pharma Gmbh and Kotobuki Pharmaceutical Co Ltd. His innovative spirit and dedication to research have been instrumental in driving forward the pharmaceutical industry's advancements.

Collaborations:

Throughout his career, Ikegai has collaborated with esteemed professionals in the field, including Masakazu Imamura and Takeshi Murakami. These collaborations have enriched his work, fostering a dynamic environment for creativity and innovation.

Conclusion:

In conclusion, Kazuhiro Ikegai stands as a testament to Japan's rich tradition of inventiveness and scientific excellence. His patents and contributions underscore his commitment to improving healthcare and advancing pharmaceutical innovation. Ikegai's visionary approach continues to inspire and shape the future of the industry.

Profile summary based on public USPTO records.